title: Pig-islet xenotransplantation: recent progress and current perspectives.
abstract: Islet xenotransplantation is one prospective treatment to bridge the gap between available human cells and needs of patients with diabetes. Pig represents an ideal candidate for obtaining such available cells. However, potential clinical application of pig islet still faces obstacles including inadequate yield of high-quality functional islets and xenorejection of the transplants. Adequate amounts of available islets can be obtained by selection of a suitable pathogen-free source herd and the development of isolation and purification method. Several studies demonstrated the feasibility of successful preclinical pig-islet xenotransplantation and provided insights and possible mechanisms of xenogeneic immune recognition and rejection. Particularly promising is the achievement of long-term insulin independence in diabetic models by means of distinct islet products and novel immunotherapeutic strategies. Nonetheless, further efforts are needed to obtain much more safety and efficacy data to translate these findings into clinic.
authors.affiliation: Department of Hepatobiliary Surgery, First Affiliated Hospital, Medical College, Xi'an Jiaotong University , Xi'an , China.
authors.forename: Hai-Tao
authors.initials: HT
authors.lastname: Zhu
authors.affiliation: Department of Hepatobiliary Surgery, First Affiliated Hospital, Medical College, Xi'an Jiaotong University , Xi'an , China.
authors.forename: Wan-Li
authors.initials: WL
authors.lastname: Wang
authors.affiliation: Department of Hepatobiliary Surgery, First Affiliated Hospital, Medical College, Xi'an Jiaotong University , Xi'an , China.
authors.forename: Liang
authors.initials: L
authors.lastname: Yu
authors.affiliation: Department of Hepatobiliary Surgery, First Affiliated Hospital, Medical College, Xi'an Jiaotong University , Xi'an , China.
authors.forename: Bo
authors.initials: B
authors.lastname: Wang
keywords: immune; islet; isolation; pig; rejection; xenotransplantation